These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus. Tsantrizos YS Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464 [TBL] [Abstract][Full Text] [Related]
4. From model complexes to metalloprotein inhibition: a synergistic approach to structure-based drug discovery. Puerta DT; Schames JR; Henchman RH; McCammon JA; Cohen SM Angew Chem Int Ed Engl; 2003 Aug; 42(32):3772-4. PubMed ID: 12923840 [No Abstract] [Full Text] [Related]
5. Design and synthesis of novel fluoropeptidomimetics as potential mimics of the transition state during peptide hydrolysis. Annedi SC; Li W; Samson S; Kotra LP J Org Chem; 2003 Feb; 68(3):1043-9. PubMed ID: 12558433 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of an orally active matrix metalloproteinase inhibitor. Yamamoto S; Nakatani S; Ikura M; Sugiura T; Nishita Y; Itadani S; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M Bioorg Med Chem; 2006 Sep; 14(18):6383-403. PubMed ID: 16765051 [TBL] [Abstract][Full Text] [Related]
7. Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors. Le Diguarher T; Chollet AM; Bertrand M; Hennig P; Raimbaud E; Sabatini M; Guilbaud N; Pierré A; Tucker GC; Casara P J Med Chem; 2003 Aug; 46(18):3840-52. PubMed ID: 12930146 [TBL] [Abstract][Full Text] [Related]
8. Novel matrix metalloproteinase inhibitors: generation of lead compounds by the in silico fragment-based approach. Takahashi K; Ikura M; Habashita H; Nishizaki M; Sugiura T; Yamamoto S; Nakatani S; Ogawa K; Ohno H; Nakai H; Toda M Bioorg Med Chem; 2005 Jul; 13(14):4527-43. PubMed ID: 15908222 [TBL] [Abstract][Full Text] [Related]
9. 3,4-Fused cyclohexyl sulfones as gamma-secretase inhibitors. Shaw D; Best J; Dinnell K; Nadin A; Shearman M; Pattison C; Peachey J; Reilly M; Williams B; Wrigley J; Harrison T Bioorg Med Chem Lett; 2006 Jun; 16(11):3073-7. PubMed ID: 16617016 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and properties of cyclopropane-derived peptidomimetics. Reichelt A; Martin SF Acc Chem Res; 2006 Jul; 39(7):433-42. PubMed ID: 16846207 [TBL] [Abstract][Full Text] [Related]
11. Model complexes of cobalt-substituted matrix metalloproteinases: tools for inhibitor design. Jacobsen FE; Breece RM; Myers WK; Tierney DL; Cohen SM Inorg Chem; 2006 Sep; 45(18):7306-15. PubMed ID: 16933932 [TBL] [Abstract][Full Text] [Related]
12. Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs). Attolino E; Calderone V; Dragoni E; Fragai M; Richichi B; Luchinat C; Nativi C Eur J Med Chem; 2010 Dec; 45(12):5919-25. PubMed ID: 20965620 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors. Cheng XC; Wang Q; Fang H; Tang W; Xu WF Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues. Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors. Zhang YM; Fan X; Xiang B; Chakravarty D; Scannevin R; Burke S; Karnachi P; Rhodes K; Jackson P Bioorg Med Chem Lett; 2006 Jun; 16(12):3096-100. PubMed ID: 16632358 [TBL] [Abstract][Full Text] [Related]
17. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors. Böttcher J; Blum A; Dörr S; Heine A; Diederich WE; Klebe G ChemMedChem; 2008 Sep; 3(9):1337-44. PubMed ID: 18720485 [TBL] [Abstract][Full Text] [Related]
18. A new role for old ligands: discerning chelators for zinc metalloproteinases. Jacobsen FE; Lewis JA; Cohen SM J Am Chem Soc; 2006 Mar; 128(10):3156-7. PubMed ID: 16522091 [TBL] [Abstract][Full Text] [Related]
19. Modeling the inhibition of peptide deformylase by hydroxamic acids: influence of the sulfur donor. Galardon E; Giorgi M; Artaud I Dalton Trans; 2007 Mar; (10):1047-52. PubMed ID: 17325780 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors. Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]